Visiongain predicts boom in pharma contract manufacturing market

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Role of CDMOs in Outsourced Pharmaceutical Manufacturing

The pharmaceutical sector stands at the crossroads of innovation...

Regional Pharma Hubs for Effective Supply Chain Outcomes

It is well to be noted that the pharmaceutical...

Incorporation of Antimicrobial Coatings in Pharmaceuticals

In the very rapidly evolving pharmaceutical spectrum, the safeguarding...

The global contract manufacturing will reach $64.07bn in 2016, according to a new report by London-based business information company Visiongain. The report, ‘Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021,’ says that the market will grow with a CAGR of 8.7% between 2010 and 2016, with finished dosage forms manufacturing driving the revenue growth. API manufacturing remained the largest market sector in 2010, accounting for 71.1% of the total market and the API manufacturers in India and China will achieve increasing demand for their services.Between 2011 and 2021, demand for contract manufacturing services will continue to come from developed market-based pharmaceutical companies, the Visiongain report says.

This decade, pharmaceutical companies will outsource increasing amounts of manufacturing, as companies focus on activities such as R&D and marketing. Growth in the biotechnology market will also provide a great opportunity for contract manufacturing organisations.

Latest stories

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Role of CDMOs in Outsourced Pharmaceutical Manufacturing

The pharmaceutical sector stands at the crossroads of innovation...

Regional Pharma Hubs for Effective Supply Chain Outcomes

It is well to be noted that the pharmaceutical...

Incorporation of Antimicrobial Coatings in Pharmaceuticals

In the very rapidly evolving pharmaceutical spectrum, the safeguarding...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back